Evaluation of the Reliability, Validity, and Acceptability of the London Measure of Unplanned Pregnancy in a U.S. Population of Women

NCT ID: NCT00306007

Last Updated: 2013-06-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

320 participants

Study Classification

OBSERVATIONAL

Study Start Date

2005-11-30

Study Completion Date

2007-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of the study is to evaluate the reliability, validity, and acceptability of the London Measure of Unplanned Pregnancy (LMUP) in a U.S. population of women. The researchers hypothesize that the LMUP will be acceptable to a U.S. population and will be reliable and valid.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The concept of "unplanned pregnancy" is used frequently in health research and policy. The majority of tools used to assess unplanned pregnancy planning have not been validated. Recently the London Measure of Unplanned Pregnancy (LMUP) has been developed and validated. The LMUP had been found to be valid and reproducible, but has not been studied outside of the United Kingdom. If we are able to validate this measure in a U.S. population, its use in studies will improve the quality of data about family planning in U.S. women.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Unplanned Pregnancy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

English prenatal

English speaking women recruited from the general OB/GYN clinic

No interventions assigned to this group

Spanish prenatal

Spanish speaking (monolingual) women recruited from the general OB/GYN clinic

No interventions assigned to this group

English abortion clinic

English speaking women recruited from the abortion clinic

No interventions assigned to this group

Spanish abortion clinic

Spanish speaking (monolingual) women recruited from the abortion clinic

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Pregnant women
* Basic literacy in English or Spanish needed to participate.

Exclusion Criteria

* Literacy level lower than 11 years of age
Minimum Eligible Age

15 Years

Maximum Eligible Age

45 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of California, San Francisco

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jody Steinauer, MD, MAS

Role: PRINCIPAL_INVESTIGATOR

University of California, San Francisco

Diane Morof, MD, MSc

Role: STUDY_DIRECTOR

University of California, San Francisco

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

San Francisco General Hospital

San Francisco, California, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

H1179-27236-01A

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Birth Control to Improve Birth Spacing
NCT05240066 ACTIVE_NOT_RECRUITING
Moms and Babies Health and Well-being
NCT06923371 RECRUITING NA
Family Planning Ahead
NCT03500952 TERMINATED NA
Persistent Poverty Counties Pregnant Women With Medicaid
NCT05415371 ENROLLING_BY_INVITATION NA